Evidence map›Paper›PMID 34084889›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)2021

The protective effect of early dietary fat consumption on Alzheimer's disease-related pathology and cognitive function in mice.

Anna Amelianchik, Jonathan Merkel, Premkumar Palanisamy, Shigeru Kaneki, Emily Hyatt, Erin H Norris

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Anna AmelianchikPatricia and John Rosenwald Laboratory of Neurobiology and Genetics The Rockefeller University New York USA.
Jonathan MerkelPatricia and John Rosenwald Laboratory of Neurobiology and Genetics The Rockefeller University New York USA.
Premkumar PalanisamyPatricia and John Rosenwald Laboratory of Neurobiology and Genetics The Rockefeller University New York USA.
Shigeru KanekiPatricia and John Rosenwald Laboratory of Neurobiology and Genetics The Rockefeller University New York USA.
Emily HyattPatricia and John Rosenwald Laboratory of Neurobiology and Genetics The Rockefeller University New York USA.
Erin H NorrisPatricia and John Rosenwald Laboratory of Neurobiology and Genetics The Rockefeller University New York USA.
Rockefeller University · USLeipzig University · DE

Funding

Role of Fibrinogen in Alzheimer's DiseaseR01NS106668 · NINDS · ROCKEFELLER UNIVERSITY · PI Erin H. Norris, SIDNEY STRICKLAND · 2018 to 2026
$5.8M
NINDS NIH HHS R01 NS106668
6 · The paper itself

Abstract

introductionIt has been suggested that obesity may influence Alzheimer's disease (AD) pathogenesis, yet the numerous publications on this topic have inconsistent results and conclusions.

methodsOur study examined the effect of varying the timing of high-fat diet (HFD) consumption on AD-related pathology and cognition in transgenic Tg6799 AD mice.

resultsHFD feeding starting at or before 3 months of age, prior to severe AD pathology, had protective effects in AD mice: reduced extracellular amyloid beta (Aβ) deposition, decreased fibrinogen extravasation into the brain parenchyma, and improved cognitive function. However, delaying HFD consumption until 6 months of age, when AD pathology is ubiquitous, reduced these protective effects in AD mice. DISCUSSION: Overall, we demonstrate that the timeline of HFD consumption may play an important role in how dietary fats affect AD pathogenesis and cognitive function.

Indexed as

Alzheimer's diseaseamyloid betafibrinogenhigh‐fat dietobesity

Identifiers

PMID34084889
PMCPMC8144936
OpenAlexW3165707786

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.